Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26080996 | 1.00 | CTSC (0.78) | CTSCKCNH2 | |
| SCHEMBL26080993 | 1.00 | CTSC (0.78) | CTSCKCNH2 | |
| SCHEMBL26080986 | 1.00 | CTSC (0.78) | CTSCKCNH2 | |
| SCHEMBL25612717 | 1.00 | CTSC (0.78) | CTSCKCNH2 | |
| SCHEMBL29433601 | 0.88 | CTSC (1.00) | CTSCKCNH2 | |
| SCHEMBL16932342 | 0.88 | CTSC (1.00) | CTSCKCNH2 | |
| SCHEMBL20162042 | 0.88 | CTSC (1.00) | CTSCKCNH2 | |
| SCHEMBL25613691 | 0.86 | CTSC (0.75) | CTSCKCNH2 | |
| SCHEMBL21263987 | 0.86 | CTSC (0.75) | CTSCKCNH2 | |
| SCHEMBL16948386 | 0.82 | CTSC (1.00) | CTSCKCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230310453-A1 | METHODS FOR EXTRACTING NEUTROPHIL SERINE PROTEASES AND TREATING DIPEPTIDYL PEPTIDASE 1-MEDIATED CONDITIONS | INSMED INCORPORATED | 2023-10-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230310453-A1 | METHODS FOR EXTRACTING NEUTROPHIL SERINE PROTEASES AND TREATING DIPEPTIDYL PEPTIDASE 1-MEDIATED CONDITIONS | PRSS3, SERPINB1, DPP3 | CTSC 7/4885KCNH2 4510/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.